MwanzoDXCM • SWX
add
DexCom Inc
Thamani ya kampuni katika soko
25.52B USD
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
MarketBeat
saa 13 zilizopita
DexCom (NASDAQ:DXCM) Stock Price Expected to Rise, Citigroup Analyst Says
0.20%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.26B | 13.12% |
Matumizi ya uendeshaji wa biashara | 469.70M | 0.60% |
Mapato halisi | 267.30M | 76.20% |
Kiwango cha faida halisi | 21.22 | 55.80% |
Mapato kwa kila hisa | 0.68 | 51.11% |
EBITDA | 388.20M | 57.36% |
Asilimia ya kodi ya mapato | 21.54% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.00B | -22.51% |
Jumla ya mali | 6.34B | -2.23% |
Jumla ya dhima | 3.59B | -17.98% |
Jumla ya hisa | 2.75B | — |
hisa zilizosalia | 384.86M | — |
Uwiano wa bei na thamani | — | — |
Faida inayotokana na mali | 11.67% | — |
Faida inayotokana mtaji | 17.10% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 267.30M | 76.20% |
Pesa kutokana na shughuli | 294.00M | -2.46% |
Pesa kutokana na uwekezaji | 306.60M | 200.95% |
Pesa kutokana na ufadhili | -1.52B | -95,037.50% |
Mabadiliko halisi ya pesa taslimu | -917.80M | -5,978.15% |
Mtiririko huru wa pesa | 85.75M | -42.68% |
Kuhusu
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1999
Makao Makuu
Tovuti
Wafanyakazi
11,050
